LSZ-102

LSZ-102 Uses, Dosage, Side Effects, Food Interaction and all others data.

LSZ-102 is under investigation in clinical trial NCT02734615 (Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers).

Trade Name LSZ-102
Generic LSZ-102
Type
Formula C25H17F3O4S
Weight Average: 470.46
Monoisotopic: 470.07996469
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
LSZ-102
LSZ-102

Innovators Monograph

You find simplified version here LSZ-102

*** Taking medicines without doctor's advice can cause long-term problems.
Share